GlobeNewswire

Bon Secours Mercy Health names Shon Baker foundation president, chief philanthropy officer
10/11/2026
Veteran philanthropy executive will strengthen donor partnerships to advance the ministry’s mission, extend its impact and support continued growth CINCINNATI, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CINCINNATI, Ohio (Nov. 10 [...]
Inviah Healthcare Technology Platform Moves from Beta to Full Launch in Illinois to Bring Doctors and Quality Healthcare Directly to Patients’ Homes
10/11/2026
Physician-led healthcare company connects patients through the Inviah mobile app with credentialed doctors on demand, making medical care more accessible and convenient CHICAGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Inviah [...]
Priovant Announces Publication of Phase 2 BEACON Results for Brepocitinib in Cutaneous Sarcoidosis in JAMA Dermatology
10/11/2026
At Week 16, 69% of participants receiving brepocitinib 45 mg achieved "Clear" or "Almost Clear" skin, with at least a 2-category improvement, compared with 0% receiving placebo Improvements in skin disease activity were [...]
Pain clinics in Ontario call for transparency amid concerns over future treatment access
10/11/2026
Save Pain Clinics seeks answers on potential changes to OHIP-funded nerve blocks and interventional pain injections for chronic pain TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Patients and clinicians across Ontario are [...]
Novartis ianalumab two-year data at ACR show further improvements in Sjögren’s disease activity
10/11/2026
Patients continuing ianalumab saw further improvement in systemic disease activity through Week 108, with no new safety findings 1 Nearly two-thirds of patients on continuous ianalumab reached low disease activity at [...]
Thanks, Birth Control Day Brings Real Stories and Accurate Information to Young People’s Social Media Feeds to Combat Misinformation
10/11/2026
Power to Decide’s 14th annual campaign meets the moment with new data and an invitation to share what birth control has made possible. Washington, D.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- On Thursday, November 12, Power [...]
Beacon Behavioral Partners Expands Houston Presence Through Partnership With One Behavioral
10/11/2026
Six-location practice strengthens Beacon’s growing network across Houston, Dallas-Fort Worth and Austin PLANO, Texas, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a growing national network of [...]
Decoy Therapeutics Named “R&D Solution of the Year” in 2026 BioTech Breakthrough Awards
10/11/2026
Recognition highlights the IMP³ACT™ platform and Designable Multi-Antivirals (D-MAVs), single drugs designed to work across many viruses CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Decoy Therapeutics, Inc. ( [...]
Zus Health Raises $33 Million in Series B Funding to Accelerate the Next Generation of Connected Healthcare
10/11/2026
Led by Drive Capital, the financing brings total funding to more than $100 million and will accelerate Zus's AI-native healthcare data platform, powered by nationwide connectivity and built for intelligent clinical [...]
Invitation to the presentation of ALK’s first nine months (Q3) 2026 results on Tuesday, 17 November 2026
10/11/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first nine months (Q3) of 2026 in the afternoon on Tuesday, 17 November 2026. The company will host a presentation for investors and analysts at [...]
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
10/11/2026
Live webcast on Thursday, November 12, 2026 at 2:40 PM ET OCALA, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it will participate in the [...]
Legend Senior Living® to manage Tuscan Gardens of Venetia Bay in Venice, Florida
10/11/2026
Legend Senior Living becomes the new manager of the well-regarded senior living community in Venice, Florida. Summary Legend Senior Living has assumed management of Tuscan Gardens of Venetia Bay, a senior living [...]
Kraig Labs Advances Commercial Spider Silk Production with New Customer Shipments and New Silkworm Research
10/11/2026
DENVER, Nov. 10, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews )— Kraig Biocraft Laboratories (OTCQB: KBLB) recently shipped its first commercial order of recombinant spider silk yarn to a globally recognized sportswear [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2026
10/11/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
10/11/2026
Nantes, le 10 novembre 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026
10/11/2026
Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026
10/11/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
CHRISTUS Health among nation's most digitally advanced health systems
10/11/2026
National recognition underscores CHRISTUS Health's commitment to using technology and innovation to enhance patient outcomes and support clinicians IRVING, Texas, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CHRISTUS Health [...]
ORYZON Reports Third Quarter 2026 Financial Results and Provides Corporate Update
10/11/2026
Updated clinical data from three iadademstat studies to be presented at ASH 2026, including encouraging results from ALICE-2 in first-line AML (95% ORR, 84% CRc and 74% CR) and FRIDA in relapsed/refractory FLT3-mutated [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum